HC Wainwright & Co. Reiterates Neutral on CareDx
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has reiterated a Neutral rating on CareDx (NASDAQ:CDNA).

October 22, 2024 | 10:56 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
HC Wainwright & Co. has reiterated a Neutral rating on CareDx, indicating no change in their outlook for the company.
The reiteration of a Neutral rating suggests that the analyst's outlook on CareDx remains unchanged. This typically indicates that the stock is expected to perform in line with the market, leading to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100